The quarterlies are indicative of the 1H23 performance. As expected, due to the wet season, 1H results are impacted. Of particular interest is whether MMI generate stronger profits in 2H23 and begin reducing debt (which was one of the major contributors to the 1H23 loss). Lots of upside here and good to see management successfully executing strategy to ramp production and reduce costs.
- Forums
- ASX - By Stock
- MMI
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-3
Featured News
Add MMI (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.002(4.26%) |
Mkt cap ! $291.8M |
Open | High | Low | Value | Volume |
4.7¢ | 4.9¢ | 4.7¢ | $522.8K | 10.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 697720 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 137983 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 335500 | 0.047 |
3 | 651376 | 0.046 |
2 | 2103549 | 0.045 |
8 | 1323653 | 0.044 |
6 | 1705104 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 137983 | 1 |
0.050 | 2244900 | 6 |
0.051 | 530000 | 3 |
0.052 | 3068288 | 10 |
0.053 | 945759 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MMI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online